Trials / Completed
CompletedNCT02193204
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 116 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine potential stress and immune systems adaptations underlying craving and relapse vulnerability in alcohol dependent (AD) individuals and social drinkers (SDs) with and without high levels of depressive symptomatology (+dep / - dep). Using the investigators experimentally validated guided imagery procedure, the investigators propose to examine the response of brain stress and immune systems to personalized guided stressful imagery using subjective, physiological and neurobiological assessments in 60 healthy controls and 60 alcoholic dependent individuals with and without depressive symptomatology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Personal Stress Imagery | The stress imagery script will be based on participants' description of a recent personal event experienced as "most stressful", and determined as such by rating it above 8 on a 10-point stress scale. These may include breakup with a significant other or job-related stress. A 5-minute 'script' of each scenario will be written using Scene Construction Questionnaires where physiological, bodily sensations regarding the event will be obtained. Scripts will then be recorded onto audiotape for guided imagery in the laboratory sessions. |
| BEHAVIORAL | Neutral Imagery | The neutral script will be developed from a personal non-alcohol-related relaxing situation. A 5-minute 'script' of each scenario will be written using Scene Construction Questionnaires where physiological, bodily sensations regarding the event will be obtained. Scripts will then be recorded onto audiotape for guided imagery in the laboratory sessions. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-07-17
- Last updated
- 2020-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02193204. Inclusion in this directory is not an endorsement.